Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)

  • Hai T. Tran
  • , Ralph G. Zinner
  • , George R. Blumenschein
  • , Yun W. Oh
  • , Vassiliki A. Papadimitrakopoulou
  • , Edward S. Kim
  • , Charles Lu
  • , Mubashira Malik
  • , Bert L. Lum
  • , Roy S. Herbst

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science